Monoclonal Antibody

Pertuzumab

Pertuzumab is a monoclonal antibody that targets HER2.

Research Overview

Pertuzumab binds to a different HER2 region than trastuzumab. It is included in CHENGENE's monoclonal antibody research portfolio.

Research Enquiry ↗

CHENGENE PRIVATE LIMITED

Advancing biotechnology through research.

Contact our team for further information about CHENGENE's research and development portfolio. Product availability, development status and regulatory details should be confirmed directly with the company.